» Articles » PMID: 36741755

Research Progress of Hydrogels As Delivery Systems and Scaffolds in the Treatment of Secondary Spinal Cord Injury

Overview
Date 2023 Feb 6
PMID 36741755
Authors
Affiliations
Soon will be listed here.
Abstract

Secondary spinal cord injury (SSCI) is the second stage of spinal cord injury (SCI) and involves vasculature derangement, immune response, inflammatory response, and glial scar formation. Bioactive additives, such as drugs and cells, have been widely used to inhibit the progression of secondary spinal cord injury. However, the delivery and long-term retention of these additives remain a problem to be solved. In recent years, hydrogels have attracted much attention as a popular delivery system for loading cells and drugs for secondary spinal cord injury therapy. After implantation into the site of spinal cord injury, hydrogels can deliver bioactive additives and induce the unidirectional growth of nerve cells as scaffolds. In addition, physical and chemical methods can endow hydrogels with new functions. In this review, we summarize the current state of various hydrogel delivery systems for secondary spinal cord injury treatment. Moreover, functional modifications of these hydrogels for better therapeutic effects are also discussed to provide a comprehensive insight into the application of hydrogels in the treatment of secondary spinal cord injury.

Citing Articles

Dual-phase SilMA hydrogel: a dynamic scaffold for sequential drug release and enhanced spinal cord repair via neural differentiation and immunomodulation.

Zhang R, Zhang M, Chen L, Jiang L, Zou C, Li N Front Bioeng Biotechnol. 2024; 12:1501488.

PMID: 39640066 PMC: 11617199. DOI: 10.3389/fbioe.2024.1501488.


An injectable decellularized extracellular matrix hydrogel with cortical neuron-derived exosomes enhances tissue repair following traumatic spinal cord injury.

Wang G, Li Q, Liu S, Li M, Liu B, Zhao T Mater Today Bio. 2024; 28:101250.

PMID: 39318371 PMC: 11421349. DOI: 10.1016/j.mtbio.2024.101250.


Modern advances in spinal cord regeneration: hydrogel combined with neural stem cells.

Rybachuk O, Nesterenko Y, Zhovannyk V Front Pharmacol. 2024; 15:1419797.

PMID: 38994202 PMC: 11236698. DOI: 10.3389/fphar.2024.1419797.


Biomaterials targeting the microenvironment for spinal cord injury repair: progression and perspectives.

Gao Y, Wang Y, Wu Y, Liu S Front Cell Neurosci. 2024; 18:1362494.

PMID: 38784712 PMC: 11111957. DOI: 10.3389/fncel.2024.1362494.


Acetyl-11-Keto-β-Boswellic Acid Accelerates the Repair of Spinal Cord Injury in Rats by Resisting Neuronal Pyroptosis with Nrf2.

Wang Y, Xiong Z, Zhang Q, Liu M, Zhang J, Qi X Int J Mol Sci. 2024; 25(1).

PMID: 38203528 PMC: 10779011. DOI: 10.3390/ijms25010358.


References
1.
Chen L, Wang W, Lin Z, Lu Y, Chen H, Li B . Conducting molybdenum sulfide/graphene oxide/polyvinyl alcohol nanocomposite hydrogel for repairing spinal cord injury. J Nanobiotechnology. 2022; 20(1):210. PMC: 9074236. DOI: 10.1186/s12951-022-01396-8. View

2.
Yao S, He F, Cao Z, Sun Z, Chen Y, Zhao H . Mesenchymal Stem Cell-Laden Hydrogel Microfibers for Promoting Nerve Fiber Regeneration in Long-Distance Spinal Cord Transection Injury. ACS Biomater Sci Eng. 2021; 6(2):1165-1175. DOI: 10.1021/acsbiomaterials.9b01557. View

3.
Wu L, He Y, Mao H, Gu Z . Bioactive hydrogels based on polysaccharides and peptides for soft tissue wound management. J Mater Chem B. 2022; 10(37):7148-7160. DOI: 10.1039/d2tb00591c. View

4.
Wang Q, He Y, Zhao Y, Xie H, Lin Q, He Z . A Thermosensitive Heparin-Poloxamer Hydrogel Bridges aFGF to Treat Spinal Cord Injury. ACS Appl Mater Interfaces. 2017; 9(8):6725-6745. DOI: 10.1021/acsami.6b13155. View

5.
Hayta E, Elden H . Acute spinal cord injury: A review of pathophysiology and potential of non-steroidal anti-inflammatory drugs for pharmacological intervention. J Chem Neuroanat. 2017; 87:25-31. DOI: 10.1016/j.jchemneu.2017.08.001. View